PharmiWeb.com - Global Pharma News & Resources
02-Jun-2021

Seagen to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that management will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 2:10 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at www.seagen.com in the Investors section.


About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.


Contacts

Peggy Pinkston
(425) 527-4160
ppinkston@seagen.com

Editor Details

  • Company:
    • Businesswire
Last Updated: 02-Jun-2021